Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,632 | 109 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $334.04 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $316.11 | 25 | $0 (2024) |
| Alkermes, Inc. | $188.42 | 12 | $0 (2024) |
| Lundbeck LLC | $158.01 | 13 | $0 (2024) |
| Almatica Pharma LLC | $103.49 | 4 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $100.17 | 5 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $83.67 | 5 | $0 (2024) |
| Tris Pharma Inc | $54.42 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.40 | 2 | $0 (2024) |
| Organon Llc | $36.69 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,273 | 92 | ABBVIE INC. ($271.64) |
| 2023 | $359.55 | 17 | Otsuka America Pharmaceutical, Inc. ($96.68) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: CNS | ||||||
| 12/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.44 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: ADHD | ||||||
| 11/27/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $3.22 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $2.39 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $1.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: VIROLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: CNS | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: VIROLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.57 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: ETONOGESTREL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 50 | 78 | $13,453 | $4,153 |
| 2022 | 10 | 250 | 422 | $44,747 | $13,162 |
| 2021 | 3 | 54 | 57 | $5,386 | $1,700 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 41 | $11,278 | $3,295 | 29.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 14 | 14 | $1,232 | $484.68 | 39.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 23 | $943.00 | $373.06 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 39 | $9,626 | $3,408 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 45 | $6,905 | $2,501 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,056 | $2,148 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $6,053 | $1,985 | 32.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 48 | 52 | $5,632 | $1,803 | 32.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 20 | 42 | $1,702 | $681.90 | 40.1% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 11 | 11 | $6,545 | $395.18 | 6.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 25 | $930.00 | $197.36 | 21.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 12 | 13 | $95.08 | $28.69 | 30.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 15 | 148 | $202.00 | $12.30 | 6.1% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 22 | 23 | $2,760 | $777.26 | 28.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $1,807 | $562.00 | 31.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 20 | 21 | $819.00 | $360.40 | 44.0% |
About Emily Reynolds, APRN
Emily Reynolds, APRN is a Family healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2021. The National Provider Identifier (NPI) number assigned to this provider is 1962095745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Reynolds, APRN has received a total of $1,632 in payments from pharmaceutical and medical device companies, with $1,273 received in 2024. These payments were reported across 109 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,632).
As a Medicare-enrolled provider, Reynolds has provided services to 354 Medicare beneficiaries, totaling 557 services with total Medicare billing of $19,014. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Evansville, IN
- Active Since 02/12/2021
- Last Updated 06/11/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1962095745
Products in Payments
- VRAYLAR (Drug) $258.27
- REXULTI (Drug) $212.40
- ARISTADA (Drug) $167.53
- ABILIFY ASIMTUFII (Drug) $145.31
- ABILIFY MAINTENA (Drug) $116.41
- CAPLYTA (Drug) $105.41
- LOREEV XR (Drug) $103.49
- HETLIOZ (Drug) $100.17
- Dyanavel XR (Drug) $54.42
- QULIPTA (Drug) $44.24
- TRINTELLIX (Drug) $39.40
- NEXPLANON (Drug) $36.69
- UZEDY (Drug) $35.37
- MAVYRET (Drug) $31.53
- Azstarys (Drug) $28.79
- Ozempic (Drug) $21.30
- ACCRUFER (Drug) $21.09
- LYBALVI (Drug) $20.89
- Auvelity (Drug) $19.90
- PAXLOVID (Drug) $19.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Evansville
Kathalene Keller Riney, Np-C, NP-C
Family — Payments: $288,394
Lacey Matheis, Msn, Np-C, MSN, NP-C
Family — Payments: $95,051
Rebecca Nance, Np-C, NP-C
Family — Payments: $28,125
Lisa Bridwell
Family — Payments: $7,329
Amy Burkett, Fnp, FNP
Family — Payments: $5,634
Leslie Gasser, Aprn, APRN
Family — Payments: $5,266